936 related articles for article (PubMed ID: 17334510)
21. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction.
van der Zee PM; Biró E; Ko Y; de Winter RJ; Hack CE; Sturk A; Nieuwland R
Clin Chem; 2006 Apr; 52(4):657-64. PubMed ID: 16439610
[TBL] [Abstract][Full Text] [Related]
22. Platelet and platelet-derived microparticle surface factor V/Va binding in whole blood: differences between neonates and adults.
Michelson AD; Rajasekhar D; Bednarek FJ; Barnard MR
Thromb Haemost; 2000 Oct; 84(4):689-94. PubMed ID: 11057871
[TBL] [Abstract][Full Text] [Related]
23. Arsenite-enhanced procoagulant activity through phosphatidylserine exposure in platelets.
Bae ON; Lim KM; Noh JY; Chung SM; Kim H; Lee CR; Park JD; Chung JH
Chem Res Toxicol; 2007 Dec; 20(12):1760-8. PubMed ID: 17915961
[TBL] [Abstract][Full Text] [Related]
24. Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation.
Keuren JF; Magdeleyns EJ; Govers-Riemslag JW; Lindhout T; Curvers J
Br J Haematol; 2006 Aug; 134(3):307-13. PubMed ID: 16848773
[TBL] [Abstract][Full Text] [Related]
25. L-carnitine inhibits a subset of platelet activation responses in chronic uraemia.
Bonomini M; Sirolli V; Dottori S; Amoroso L; Di Liberato L; Arduini A
Nephrol Dial Transplant; 2007 Sep; 22(9):2623-9. PubMed ID: 17478491
[TBL] [Abstract][Full Text] [Related]
26. Measurement of phosphatidylserine exposure during storage of platelet concentrates using the novel probe lactadherin: a comparison study with annexin V.
Albanyan AM; Murphy MF; Rasmussen JT; Heegaard CW; Harrison P
Transfusion; 2009 Jan; 49(1):99-107. PubMed ID: 18954406
[TBL] [Abstract][Full Text] [Related]
27. Effects of platelets and platelet-derived material on the activated partial thromboplastin time (Cephotest) coagulation test.
Mendelsohn EE; Solum NO; Brosstad F
Scand J Clin Lab Invest; 2005; 65(4):321-32. PubMed ID: 16076687
[TBL] [Abstract][Full Text] [Related]
28. Vitamin E inhibition on platelet procoagulant activity: involvement of aminophospholipid translocase activity.
Kim JE; Han M; Hanl KS; Kim HK
Thromb Res; 2011 May; 127(5):435-42. PubMed ID: 21296386
[TBL] [Abstract][Full Text] [Related]
29. Effect of P-selectin on phosphatidylserine exposure and surface-dependent thrombin generation on monocytes.
del Conde I; Nabi F; Tonda R; Thiagarajan P; López JA; Kleiman NS
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1065-70. PubMed ID: 15705928
[TBL] [Abstract][Full Text] [Related]
30. The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity.
Kumar R; Béguin S; Hemker HC
Thromb Haemost; 1995 Sep; 74(3):962-8. PubMed ID: 8571330
[TBL] [Abstract][Full Text] [Related]
31. Plasma factor V activation is prevented by activated protein C in the presence of phospholipid vesicles, not platelets.
Solymoss S; Nguyen KT
Thromb Haemost; 1993 Feb; 69(2):124-9. PubMed ID: 8456424
[TBL] [Abstract][Full Text] [Related]
32. Persistence of procoagulant surface expression on activated human platelets: involvement of apoptosis and aminophospholipid translocase activity.
Leung R; Gwozdz AM; Wang H; Bang KW; Packham MA; Freedman J; Rand ML
J Thromb Haemost; 2007 Mar; 5(3):560-70. PubMed ID: 17155950
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous engagement of thrombin and Fc gamma RIIA receptors results in platelets expressing high levels of procoagulant proteins.
Batar P; Dale GL
J Lab Clin Med; 2001 Dec; 138(6):393-402. PubMed ID: 11753286
[TBL] [Abstract][Full Text] [Related]
34. Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets.
Miletich JP; Majerus DW; Majerus PW
J Clin Invest; 1978 Oct; 62(4):824-31. PubMed ID: 701480
[TBL] [Abstract][Full Text] [Related]
35. Shedding of procoagulant microparticles from unstimulated platelets by integrin-mediated destabilization of actin cytoskeleton.
Cauwenberghs S; Feijge MA; Harper AG; Sage SO; Curvers J; Heemskerk JW
FEBS Lett; 2006 Oct; 580(22):5313-20. PubMed ID: 16979629
[TBL] [Abstract][Full Text] [Related]
36. Platelet heterogeneity: variation in coagulation complexes on platelet subpopulations.
Kempton CL; Hoffman M; Roberts HR; Monroe DM
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):861-6. PubMed ID: 15653564
[TBL] [Abstract][Full Text] [Related]
37. Levels of procoagulant microparticles expressing phosphatidylserine contribute to bleeding phenotype in patients with inherited thrombocytopenia.
Brøns N; Leinøe E; Salado-Jimena JA; Rossing M; Ostrowski SR
Blood Coagul Fibrinolysis; 2021 Oct; 32(7):480-490. PubMed ID: 34475331
[TBL] [Abstract][Full Text] [Related]
38. Serotonergic mechanisms enhance platelet-mediated thrombogenicity.
Galan AM; Lopez-Vilchez I; Diaz-Ricart M; Navalon F; Gomez E; Gasto C; Escolar G
Thromb Haemost; 2009 Sep; 102(3):511-9. PubMed ID: 19718472
[TBL] [Abstract][Full Text] [Related]
39. Platelet characteristic antigens of CD34+ cells in cryopreserved cord blood: a study of platelet-derived microparticles in transplant processing.
Liu B; Chen JS; Cao M; Gu SL; Liao C; Li DZ; Zhong HZ
Vox Sang; 2004 Aug; 87(2):96-104. PubMed ID: 15355500
[TBL] [Abstract][Full Text] [Related]
40. Platelet-derived microparticles and coagulation activation in breast cancer patients.
Toth B; Liebhardt S; Steinig K; Ditsch N; Rank A; Bauerfeind I; Spannagl M; Friese K; Reininger AJ
Thromb Haemost; 2008 Oct; 100(4):663-9. PubMed ID: 18841290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
